Minireviews
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Dec 6, 2022; 10(34): 12494-12499
Published online Dec 6, 2022. doi: 10.12998/wjcc.v10.i34.12494
Pediatric kidney transplantation during the COVID-19 pandemic
Hiroshi Tamura
Hiroshi Tamura, Department of Pediatrics, Kumamoto University, Kumamoto 860-8556, Japan
Author contributions: Tamura H performed the analysis and wrote the paper.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Hiroshi Tamura, MD, PhD, Assistant Professor, Department of Pediatrics, Kumamoto University, Chuo-ku Honjyo 1-1-1, Kumamoto 860-8556, Japan. bohm1905ht@kuh.kumamoto-u.ac.jp
Received: September 17, 2022
Peer-review started: September 17, 2022
First decision: October 24, 2022
Revised: October 31, 2022
Accepted: November 10, 2022
Article in press: November 10, 2022
Published online: December 6, 2022
Processing time: 76 Days and 9.7 Hours
Core Tip

Core Tip: Nearly 60 years have passed since dialysis was first introduced in Japan in 1965 for children with end-stage renal disease. During this period, dialysis therapy, renal transplantation, and renal failure-related treatments (especially clinical applications of erythropoietin and growth hormone) have made remarkable progress, and the era of focusing on prolonging the life of children with end-stage renal disease has completely passed. Patients receiving kidney transplants are at a higher risk of death than the general population during the coronavirus disease 2019 pandemic. However, pediatric cases of severe disease are rare and without deaths. We will continue to provide kidney transplantation medical care by implementing infection prevention measures and treatment based on the latest evidence, and by promoting donated kidney transplantation. We also hope that pediatric patients with renal failure will grow up to be healthy, both physically and mentally, and become independent members of society, just like healthy children.